|
|||||
|
|
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer |
|
| Authors: | Federica Miglietta Maria Vittoria Dieci Vassilena Tsvetkova Gaia Griguolo Grazia Vernaci Alice Menichetti Giovanni Faggioni Tommaso Giarratano Eleonora Mioranza Elisa Genovesi Enrico Cumerlato Michele Bottosso Tania Saibene Silvia Michieletto Marcello Lo Mele Pierfranco Conte Valentina Guarneri |
| Affiliation: | 1. Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy;2. Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy Anatomy and Histology Unit, Azienda Ospedaliera di Padova, Padova, Italy;3. Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy Division of Oncology 2, Istituto Oncologico Veneto I.R.C.C.S, Padova, Italy;4. Division of Oncology 2, Istituto Oncologico Veneto I.R.C.C.S, Padova, Italy;5. Breast Surgery Unit, Istituto Oncologico Veneto I.R.C.C.S, Padova, Italy;6. Anatomy and Histology Unit, Azienda Ospedaliera di Padova, Padova, Italy |
| Abstract: | |
| Keywords: | Breast cancer Residual cancer burden Residual proliferative cancer burden Ki67 Neoadjuvant chemotherapy |